Paper8201385
Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.
Michel G and 9 others. J Clin Oncol, 1994. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle. Papers, record 8201385. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8201385
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Bone Marrow Transplantation | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Whole-Body Irradiation | Major topic |
| Busulfan | |
| Child | |
| Child, Preschool | |
| Combined Modality Therapy | |
| Cyclophosphamide | |
| Female | |
| Graft vs Host Disease | |
| Humans | |
| Male | |
| Recurrence | |
| Remission Induction | |
| Survival Rate |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41949966 | [Allogeneic hematopoietic stem cell transplantation in children's acute myeloblastic leukemia: Survival and relapse]. | Tunis Med | 2025 | https://conductscience.org/library/papers/41949966 | PubMed |
| 34546410 | Neurological complications in Chinese children undergoing hematopoietic stem cell transplantation. | Childs Nerv Syst | 2021 | https://conductscience.org/library/papers/34546410 | PubMed |
| 31996791 | Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study. | Bone Marrow Transplant | 2020 | https://conductscience.org/library/papers/31996791 | PubMed |
| 31913492 | Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant. | JAMA Netw Open | 2020 | https://conductscience.org/library/papers/31913492 | PubMed |
| 31536825 | Long-Term Outcomes of Patients with Acute Myelogenous Leukemia Treated with Myeloablative Fractionated Total Body Irradiation TBI-Based Conditioning with a Tacrolimus- and Sirolimus-Based Graft-versus-Host Disease Prophylaxis Regimen: 6-Year Follow-Up from a Single Center. | Biol Blood Marrow Transplant | 2020 | https://conductscience.org/library/papers/31536825 | PubMed |
| 30804484 | Retrospective cohort study comparing the outcomes of intravenous busulfan vs. total-body irradiation after single cord blood transplantation. | Bone Marrow Transplant | 2019 | https://conductscience.org/library/papers/30804484 | PubMed |
| 25616572 | Late cardiomyopathy in childhood acute myeloid leukemia survivors: a study from the L.E.A. program. | Haematologica | 2015 | https://conductscience.org/library/papers/25616572 | PubMed |
| 25387094 | Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study. | Bone Marrow Transplant | 2015 | https://conductscience.org/library/papers/25387094 | PubMed |
| 24317131 | Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire. | Bone Marrow Transplant | 2014 | https://conductscience.org/library/papers/24317131 | PubMed |
| 24065243 | Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. | Blood | 2013 | https://conductscience.org/library/papers/24065243 | PubMed |
| 23103678 | Allo-SCT using BU, CY and melphalan for children with AML in second CR. | Bone Marrow Transplant | 2013 | https://conductscience.org/library/papers/23103678 | PubMed |
| 22455797 | Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: towards individualized dosing. | Clin Pharmacokinet | 2012 | https://conductscience.org/library/papers/22455797 | PubMed |
| 20307709 | Hematopoietic stem cell transplantation for leukemia. | Pediatr Clin North Am | 2010 | https://conductscience.org/library/papers/20307709 | PubMed |
| 19011666 | Early outcomes after allogeneic hematopoietic SCT in pediatric patients with hematologic malignancies following single fraction TBI. | Bone Marrow Transplant | 2009 | https://conductscience.org/library/papers/19011666 | PubMed |
| 18560412 | Successful outcome of allo-SCT in high-risk pediatric AML using chemotherapy-only conditioning and post transplant immunotherapy. | Bone Marrow Transplant | 2008 | https://conductscience.org/library/papers/18560412 | PubMed |
| 18223695 | The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model. | Bone Marrow Transplant | 2008 | https://conductscience.org/library/papers/18223695 | PubMed |
| 17988993 | Long-term follow-up of busulfan, etoposide, and nimustine hydrochloride (ACNU) or melphalan as conditioning regimens for childhood acute leukemia and lymphoma. | Int J Hematol | 2007 | https://conductscience.org/library/papers/17988993 | PubMed |
| 17563741 | Autologous bone marrow transplantation for children with AML in first remission. | Bone Marrow Transplant | 2007 | https://conductscience.org/library/papers/17563741 | PubMed |
| 16121218 | Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group. | Leukemia | 2005 | https://conductscience.org/library/papers/16121218 | PubMed |
| 15064687 | I.V. busulfan in pediatrics: a novel dosing to improve safety/efficacy for hematopoietic progenitor cell transplantation recipients. | Bone Marrow Transplant | 2004 | https://conductscience.org/library/papers/15064687 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8201385
GET https://conductscience.org/api/papers/v1/8201385/cited_by?page=2